Kualitas Hidup Penderita Melasma Pada Ibu-Ibu Pengunjung Pos Pelayanan Terpadu (Posyandu) Di Kelurahan Tanjung Rejo
DAFTAR PUSTAKA
Airlangga University Press, 2008. Atlas Penyakit Kulit & Kelamin. Bagian SMF
Ilmu Kesehatan Kulit dan Kelamin:173-175.
Ali, R., Aman, S., Nadeem, M., Kazmi, A.H., 2013. Quality of life in patients of
melasma. Department of Dermatology, King Edward Medical University/
Mayo Hospital, Lahore, Pakistan:1-6.
Arellano I, León G, Luna C, 2006. Quality of life in Mexican patients with
melasma. Cosmet Dermatol.;5:343-5.
Balkrishnan R, McMichael A, Camacho F et al, 2003.
Development
and
validation of a health related quality of life instrument for women with
melasma. Br J Dermatol.;149:572-7.
Bleehen, S.S., Anstey, A.V., 2004. Disorder of skin colour : Ephelid. In : Burns,
T., Breathnach, S., Cox, N., Griffiths, C., ed. Rook’s textbook of
dermatology. Edisi ke 7. Massachusetts: Blackwell.;19.
Brown, R.G., Burns, T., 2005. Dermatologi Edisi Kedelapan. Jakarta: Erlangga,
126-132.
Cestari, T.F., et al., 2006. Validation of a melasma quality of life questionnaire for
Brazilian Portuguese language: the MelasQoL-BP study and improvement
of QoL of melasma patients after triple combination therapy. Department
of Dermatology, Federal University of Rio Grande do Sul Hospital de
Clinicas de Porto Alegre, Porto Alegre, Brazil:1-8.
Chan, R., et al, 2008. A Randomized Controlled Trial of the Efficacy and Safety of
Fixed Triple Combination (Fluocinolone Acetonide 0.01%, Hydroquinone
4%, Tretinoin 0.05%) Compared with Hydroquinone 4% Cream in Asian
Patient with Moderate to Severe Melasma. Br J Dermatol;159:697-703.
Universitas Sumatera Utara
Chen, S.C., 2012. Melasma Quality of Life Measures. In: Chen, S.C, ed. Quality
of Life Issues in Dermatology.
Damayanti, N., Listiawan, M.Y., 2004. Fisiologi dan Biokomia Pigmentasi Kulit.
Berkala Ilmu Penyakit Kulit dan Kelamin;16(2): 156-62.
Dominguez, A.R., Balkrishnan, R., Ellzey, A.R., Pandya, A.G., 2006. Melasma
in Latina patients: Cross-cultural adaptation and validation of a qualityof-life questionnaire in Spanish language. J Am Acad Dermatol.;55:5966.
Davis, E.C., Callender, V.D., 2010. Postinflammatory Hyperpigmentation.
Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921758/
[Accessed 01 April 2014].
Geria, A.N., Tajrian, A.L., Kihiczak, G., Shcwartz, R.A., 2009. Minocyclineinduced
skin
pigmentation:
an
update.
http://www.ncbi.nlm.nih.gov/pubmed/19595269
Available
[Accessed
from:
01
April
2014].
Hadiyati, P.U., Sibero, H.T., Apriliana, E., 2013. Quality of Life of Melasma
Patients at Dr. H. Abdul Moeloek Hospital in Lampung. Medical Faculty,
Lampung University, Indonesia:1-9.
Handel, A.C., Lima, P.B., Tonolli, V.M., Miot, L.D., Miot, H.A., 2014. Risk
factors for facial melasma in women: a case-control study. Available
from:
http://www.ncbi.nlm.nih.gov/pubmed/24749693
[Accessed
30
March 2014].
Jimbow, K., Minamitsuji, Y., 2001. Topical Therapies for Melasma and
Disorders of Hyperpigmentation. Dermatologic Therapy;14:35-45.
Universitas Sumatera Utara
Kariosentono, H., 2002. Kelainan pigmentasi dan penuaan dini serta peran
pendidikan kedokteran di bidang ilmu kesehatan kulit dan kelamin.
Universitas
Sebelas
Maret.
Available
from:
http://si.uns.ac.id/profil/uploadpublikasi/pengukuhan/pengukuhan_harijon
o.pdf [Accessed 02 April 2014].
Laperee, H., Boone, B., Schepper, S.D., et al., 2008. Hypomelanoses and
Hypermelanoses. In : Fitzpatrick, T.B., Wolff, K., ed. Dermatology in
general medicine. Edisi ke 7. New York, McGraw – Hill. 622-640.
Lawrence, N., Cox, S.E., Brody, H.J., 1997. Treatment of Melasma with Jessner’s
Solution versus Glycolic Acid: A Comparison of Clinical Efficacy and
Evaluation of the Predictive Ability of Wood’s Light Examination. J Am
Acad Dermatol ; 36(4):589-93.
Lin, J.Y., Chan, H.H., 2006. Pigmentary Disorders in Asian Skin: Treatment with
Laser
and
Intense
Pulsed
Light
Sources.
Available
from:
http://medscape.com/viewarticle/547276_4 [Accessed 01 April 2014].
Montemarano,
A.D.,
Lyford,
H.,
2012.
Melasma.
Available
from:
http://emedicine.medscape.com/article/1068640-overview [Accessed 23
March 2014].
Murti, B., 2011. Struktur Riset. Institute of Health Economic and Policy Studies
(IHEPS), Bagian Ilmu Kesehatan Masyarakat,
Fakultas Kedokteran,
Universitas Sebelas Maret: 1-21.
Nicolaidou,
E.,
Antoniou,
presentation,
and
C.,
Katsambas,
diagnosis of
facial
A., 2007. Origin,
hypermelanoses.
clinical
Dermatol
Clin.;25:321-6.
Notoatmodjo S. Metodologi Penelitian Kesehatan. Jakarta : Rineka Cipta ; 2003.
Rekam Medik Bagian Ilmu Kesehatan Kulit dan Kelamin RSUP. H. Adam Malik
Medan Tahun 2009.
Universitas Sumatera Utara
Rigopoulos, D., Gregoriou, S., Katsambas, A., 2007. Hyperpigmentation and
Melasma. J Cosmet Dermatol;6:195-202.
Rikyanto, H., 2004. Profil kasus melasma pelanggan klinik kosmetik di
RSUD
kota
Yogyakarta.
Available
from:
www.perdoski.or.id/index.php/public/information/mdvi-detail-content/87.
[Accessed 23 March 2014].
Roberts , W.E., 2009.
Melasma.
In:
Kelly
AP,
Taylor
SC,
editor.
Dermatology for skin of colour. New York, McGraw-Hill. 332-336.
Rossi, A., Perez, M.I., 2011. Cosmetic Concerns in Melasma, Part 1:
Pathogenesis and Clinical Considerations. Cosmetic Dermatology
Volume 24.
Sarkar. R., Chugh, S., Garg, V.J., 2012. Newer and Upcoming Therapies for
Melasma. Indian Journal of Dermatology, Venereology, and Leprology
Volume 78.
Scherdin, U., et al, 2008. Skin-Lightening Effect of a New Face Care Product in
Patients with Melasma. J Cosmet Dermatol;7:68-75.
Shcwartz, R.A., 2013. Erythema Dyschromicum Perstans. Available from:
http://emedicine.medscape.com/article/1122807-overview [Accessed 01
April 2014].
Sheth, V.M., Pandya, A.G., 2011. Melasma: A Comprehensive Update part two. J
Am Acad Dermatol Volume 65, Number 4.
Shudarmono A, Febrianti A, Rata I, Bernadette I. Epidemiologi Melasma di
Poliklinik Departemen Ilmu Kesehatan Kulit dan Kelamin RS. Dr. Cipto
Mangunkusumo Tahun 2004. Media Dermato Venereologi Indonesia
2006;33(1).
Universitas Sumatera Utara
Situm, M., Bulat, V., Buljan, M., Puljiz, Z., Bolanca, Z., 2010. Senile lentigocosmetic or medical issue of the elderly population. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21302707 [Accessed 01 April 2014]
Soepardiman, L., 2007. Kelainan pigmen. Ilmu Penyakit Kulit dan Kelamin.
Edisi ke 5. Balai Penerbit, Jakarta. 289-95.
Torok, H.M., Jones, T., Rich, P., Smith, S., Tschen, E., 2005. Hydroquinone 4%,
Tretinoin 0,05%, Fluocinolone Acetonide 0,01%: A Safe and Efficacious
12-Month Treatment for Melasma. Therapeutic for the Clinician, Cutis;5762.
Yamaquchi, Y., Hearing, V.J., 2014. Melanocytes and their Diseases. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/24789876 [Accessed 03 April
2014].
Universitas Sumatera Utara
Airlangga University Press, 2008. Atlas Penyakit Kulit & Kelamin. Bagian SMF
Ilmu Kesehatan Kulit dan Kelamin:173-175.
Ali, R., Aman, S., Nadeem, M., Kazmi, A.H., 2013. Quality of life in patients of
melasma. Department of Dermatology, King Edward Medical University/
Mayo Hospital, Lahore, Pakistan:1-6.
Arellano I, León G, Luna C, 2006. Quality of life in Mexican patients with
melasma. Cosmet Dermatol.;5:343-5.
Balkrishnan R, McMichael A, Camacho F et al, 2003.
Development
and
validation of a health related quality of life instrument for women with
melasma. Br J Dermatol.;149:572-7.
Bleehen, S.S., Anstey, A.V., 2004. Disorder of skin colour : Ephelid. In : Burns,
T., Breathnach, S., Cox, N., Griffiths, C., ed. Rook’s textbook of
dermatology. Edisi ke 7. Massachusetts: Blackwell.;19.
Brown, R.G., Burns, T., 2005. Dermatologi Edisi Kedelapan. Jakarta: Erlangga,
126-132.
Cestari, T.F., et al., 2006. Validation of a melasma quality of life questionnaire for
Brazilian Portuguese language: the MelasQoL-BP study and improvement
of QoL of melasma patients after triple combination therapy. Department
of Dermatology, Federal University of Rio Grande do Sul Hospital de
Clinicas de Porto Alegre, Porto Alegre, Brazil:1-8.
Chan, R., et al, 2008. A Randomized Controlled Trial of the Efficacy and Safety of
Fixed Triple Combination (Fluocinolone Acetonide 0.01%, Hydroquinone
4%, Tretinoin 0.05%) Compared with Hydroquinone 4% Cream in Asian
Patient with Moderate to Severe Melasma. Br J Dermatol;159:697-703.
Universitas Sumatera Utara
Chen, S.C., 2012. Melasma Quality of Life Measures. In: Chen, S.C, ed. Quality
of Life Issues in Dermatology.
Damayanti, N., Listiawan, M.Y., 2004. Fisiologi dan Biokomia Pigmentasi Kulit.
Berkala Ilmu Penyakit Kulit dan Kelamin;16(2): 156-62.
Dominguez, A.R., Balkrishnan, R., Ellzey, A.R., Pandya, A.G., 2006. Melasma
in Latina patients: Cross-cultural adaptation and validation of a qualityof-life questionnaire in Spanish language. J Am Acad Dermatol.;55:5966.
Davis, E.C., Callender, V.D., 2010. Postinflammatory Hyperpigmentation.
Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921758/
[Accessed 01 April 2014].
Geria, A.N., Tajrian, A.L., Kihiczak, G., Shcwartz, R.A., 2009. Minocyclineinduced
skin
pigmentation:
an
update.
http://www.ncbi.nlm.nih.gov/pubmed/19595269
Available
[Accessed
from:
01
April
2014].
Hadiyati, P.U., Sibero, H.T., Apriliana, E., 2013. Quality of Life of Melasma
Patients at Dr. H. Abdul Moeloek Hospital in Lampung. Medical Faculty,
Lampung University, Indonesia:1-9.
Handel, A.C., Lima, P.B., Tonolli, V.M., Miot, L.D., Miot, H.A., 2014. Risk
factors for facial melasma in women: a case-control study. Available
from:
http://www.ncbi.nlm.nih.gov/pubmed/24749693
[Accessed
30
March 2014].
Jimbow, K., Minamitsuji, Y., 2001. Topical Therapies for Melasma and
Disorders of Hyperpigmentation. Dermatologic Therapy;14:35-45.
Universitas Sumatera Utara
Kariosentono, H., 2002. Kelainan pigmentasi dan penuaan dini serta peran
pendidikan kedokteran di bidang ilmu kesehatan kulit dan kelamin.
Universitas
Sebelas
Maret.
Available
from:
http://si.uns.ac.id/profil/uploadpublikasi/pengukuhan/pengukuhan_harijon
o.pdf [Accessed 02 April 2014].
Laperee, H., Boone, B., Schepper, S.D., et al., 2008. Hypomelanoses and
Hypermelanoses. In : Fitzpatrick, T.B., Wolff, K., ed. Dermatology in
general medicine. Edisi ke 7. New York, McGraw – Hill. 622-640.
Lawrence, N., Cox, S.E., Brody, H.J., 1997. Treatment of Melasma with Jessner’s
Solution versus Glycolic Acid: A Comparison of Clinical Efficacy and
Evaluation of the Predictive Ability of Wood’s Light Examination. J Am
Acad Dermatol ; 36(4):589-93.
Lin, J.Y., Chan, H.H., 2006. Pigmentary Disorders in Asian Skin: Treatment with
Laser
and
Intense
Pulsed
Light
Sources.
Available
from:
http://medscape.com/viewarticle/547276_4 [Accessed 01 April 2014].
Montemarano,
A.D.,
Lyford,
H.,
2012.
Melasma.
Available
from:
http://emedicine.medscape.com/article/1068640-overview [Accessed 23
March 2014].
Murti, B., 2011. Struktur Riset. Institute of Health Economic and Policy Studies
(IHEPS), Bagian Ilmu Kesehatan Masyarakat,
Fakultas Kedokteran,
Universitas Sebelas Maret: 1-21.
Nicolaidou,
E.,
Antoniou,
presentation,
and
C.,
Katsambas,
diagnosis of
facial
A., 2007. Origin,
hypermelanoses.
clinical
Dermatol
Clin.;25:321-6.
Notoatmodjo S. Metodologi Penelitian Kesehatan. Jakarta : Rineka Cipta ; 2003.
Rekam Medik Bagian Ilmu Kesehatan Kulit dan Kelamin RSUP. H. Adam Malik
Medan Tahun 2009.
Universitas Sumatera Utara
Rigopoulos, D., Gregoriou, S., Katsambas, A., 2007. Hyperpigmentation and
Melasma. J Cosmet Dermatol;6:195-202.
Rikyanto, H., 2004. Profil kasus melasma pelanggan klinik kosmetik di
RSUD
kota
Yogyakarta.
Available
from:
www.perdoski.or.id/index.php/public/information/mdvi-detail-content/87.
[Accessed 23 March 2014].
Roberts , W.E., 2009.
Melasma.
In:
Kelly
AP,
Taylor
SC,
editor.
Dermatology for skin of colour. New York, McGraw-Hill. 332-336.
Rossi, A., Perez, M.I., 2011. Cosmetic Concerns in Melasma, Part 1:
Pathogenesis and Clinical Considerations. Cosmetic Dermatology
Volume 24.
Sarkar. R., Chugh, S., Garg, V.J., 2012. Newer and Upcoming Therapies for
Melasma. Indian Journal of Dermatology, Venereology, and Leprology
Volume 78.
Scherdin, U., et al, 2008. Skin-Lightening Effect of a New Face Care Product in
Patients with Melasma. J Cosmet Dermatol;7:68-75.
Shcwartz, R.A., 2013. Erythema Dyschromicum Perstans. Available from:
http://emedicine.medscape.com/article/1122807-overview [Accessed 01
April 2014].
Sheth, V.M., Pandya, A.G., 2011. Melasma: A Comprehensive Update part two. J
Am Acad Dermatol Volume 65, Number 4.
Shudarmono A, Febrianti A, Rata I, Bernadette I. Epidemiologi Melasma di
Poliklinik Departemen Ilmu Kesehatan Kulit dan Kelamin RS. Dr. Cipto
Mangunkusumo Tahun 2004. Media Dermato Venereologi Indonesia
2006;33(1).
Universitas Sumatera Utara
Situm, M., Bulat, V., Buljan, M., Puljiz, Z., Bolanca, Z., 2010. Senile lentigocosmetic or medical issue of the elderly population. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/21302707 [Accessed 01 April 2014]
Soepardiman, L., 2007. Kelainan pigmen. Ilmu Penyakit Kulit dan Kelamin.
Edisi ke 5. Balai Penerbit, Jakarta. 289-95.
Torok, H.M., Jones, T., Rich, P., Smith, S., Tschen, E., 2005. Hydroquinone 4%,
Tretinoin 0,05%, Fluocinolone Acetonide 0,01%: A Safe and Efficacious
12-Month Treatment for Melasma. Therapeutic for the Clinician, Cutis;5762.
Yamaquchi, Y., Hearing, V.J., 2014. Melanocytes and their Diseases. Available
from: http://www.ncbi.nlm.nih.gov/pubmed/24789876 [Accessed 03 April
2014].
Universitas Sumatera Utara